by Sean Ruck
, Contributing Editor | October 13, 2015
From the October 2015 issue of HealthCare Business News magazine
HCBN: What tops the membership’s wish list for what they want from the association?
Members want many things. They want a strong national meeting, scientific expertise, platforms to present their new findings, educational opportunities and strong representation for radiation oncology interests on Capitol Hill.
HCBN: What are the biggest challenges facing ASTRO today?
Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs
Our biggest challenge is to continue to show how our modality adds value to medical care. We strongly believe it does and have data that support that, but we must continue to get that data in front of the other specialties and insurance companies to reinforce that idea.
HCBN: Have there been any breakthroughs or is there any ongoing research you’re particularly excited about?
There are some. I can’t talk about the results of the abstracts because they’re still embargoed, but there are some phase 2 and phase 3 studies that will be revealed at the show that are very exciting in their results.
HCBN: What do you think the field will look like 10 years from now?
I think it will continue to grow in both its technological ability to deliver radiation therapy and continue to grow overall in numbers. As our systemic therapy becomes more robust, the use of radiation therapy will continue to grow, so I see a very bright future for those reasons. Despite it being a single modality, if you look at the history over the last few decades, we continue to increase our effectiveness and the indications it’s used for.
HCBN: What abilities will radiation oncologists need to be competitive in the future?
They’ll need to maintain clinical skills in the technical delivery of therapy and understand other fields to be able to integrate other treatments. They’ll need to develop research abilities and undertake trials to prove the value of radiation oncology in the delivery of care, and I think that’s a skill that’s just starting to develop more fully.Back to HCB News